Cargando…
CITN-06: a Phase I/expansion trial of alt-803, an IL-15 superagonist, in patients with advanced melanoma
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288745/ http://dx.doi.org/10.1186/2051-1426-2-S3-P79 |
| _version_ | 1782352017733189632 |
|---|---|
| author | Margolin, Kim Wong, Hing C Morishima, Chihiro Hernandez, Liza Ernstoff, Marc Rhode, Peter R Waldmann, Thomas A |
| author_facet | Margolin, Kim Wong, Hing C Morishima, Chihiro Hernandez, Liza Ernstoff, Marc Rhode, Peter R Waldmann, Thomas A |
| author_sort | Margolin, Kim |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4288745 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42887452015-01-15 CITN-06: a Phase I/expansion trial of alt-803, an IL-15 superagonist, in patients with advanced melanoma Margolin, Kim Wong, Hing C Morishima, Chihiro Hernandez, Liza Ernstoff, Marc Rhode, Peter R Waldmann, Thomas A J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288745/ http://dx.doi.org/10.1186/2051-1426-2-S3-P79 Text en Copyright © 2014 Margolin et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Margolin, Kim Wong, Hing C Morishima, Chihiro Hernandez, Liza Ernstoff, Marc Rhode, Peter R Waldmann, Thomas A CITN-06: a Phase I/expansion trial of alt-803, an IL-15 superagonist, in patients with advanced melanoma |
| title | CITN-06: a Phase I/expansion trial of alt-803, an IL-15 superagonist, in patients with advanced melanoma |
| title_full | CITN-06: a Phase I/expansion trial of alt-803, an IL-15 superagonist, in patients with advanced melanoma |
| title_fullStr | CITN-06: a Phase I/expansion trial of alt-803, an IL-15 superagonist, in patients with advanced melanoma |
| title_full_unstemmed | CITN-06: a Phase I/expansion trial of alt-803, an IL-15 superagonist, in patients with advanced melanoma |
| title_short | CITN-06: a Phase I/expansion trial of alt-803, an IL-15 superagonist, in patients with advanced melanoma |
| title_sort | citn-06: a phase i/expansion trial of alt-803, an il-15 superagonist, in patients with advanced melanoma |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288745/ http://dx.doi.org/10.1186/2051-1426-2-S3-P79 |
| work_keys_str_mv | AT margolinkim citn06aphaseiexpansiontrialofalt803anil15superagonistinpatientswithadvancedmelanoma AT wonghingc citn06aphaseiexpansiontrialofalt803anil15superagonistinpatientswithadvancedmelanoma AT morishimachihiro citn06aphaseiexpansiontrialofalt803anil15superagonistinpatientswithadvancedmelanoma AT hernandezliza citn06aphaseiexpansiontrialofalt803anil15superagonistinpatientswithadvancedmelanoma AT ernstoffmarc citn06aphaseiexpansiontrialofalt803anil15superagonistinpatientswithadvancedmelanoma AT rhodepeterr citn06aphaseiexpansiontrialofalt803anil15superagonistinpatientswithadvancedmelanoma AT waldmannthomasa citn06aphaseiexpansiontrialofalt803anil15superagonistinpatientswithadvancedmelanoma |